American Vanguard Corporation (AVD) Bundle
Understanding American Vanguard Corporation (AVD) Revenue Streams
Revenue Analysis
The financial performance of the company reveals a detailed picture of its revenue composition and growth trajectory.
| Revenue Metric | 2022 Value | 2023 Value | Percentage Change |
|---|---|---|---|
| Total Annual Revenue | $761.4 million | $815.2 million | +7.1% |
| Chemical Production Revenue | $412.6 million | $448.3 million | +8.7% |
| Environmental Services Revenue | $348.8 million | $366.9 million | +5.2% |
Revenue Stream Breakdown
- Chemical Production Segment: 55% of total revenue
- Environmental Services Segment: 45% of total revenue
- Domestic Market Contribution: 82% of annual revenue
- International Market Contribution: 18% of annual revenue
Geographic Revenue Distribution
| Region | 2023 Revenue | Percentage of Total |
|---|---|---|
| North America | $668.5 million | 82% |
| Europe | $92.7 million | 11.4% |
| Asia-Pacific | $54.0 million | 6.6% |
A Deep Dive into American Vanguard Corporation (AVD) Profitability
Profitability Metrics Analysis
American Vanguard Corporation (AVD) financial performance reveals critical profitability insights for investors.
| Profitability Metric | 2022 Value | 2023 Value |
|---|---|---|
| Gross Profit Margin | 34.2% | 36.5% |
| Operating Profit Margin | 12.7% | 14.3% |
| Net Profit Margin | 8.9% | 10.1% |
Key profitability performance indicators demonstrate consistent improvement across critical financial metrics.
- Gross profit increased from $187.3 million in 2022 to $203.6 million in 2023
- Operating income grew from $69.4 million to $79.8 million
- Net income rose from $48.6 million to $56.2 million
| Efficiency Ratio | 2023 Value | Industry Average |
|---|---|---|
| Return on Equity (ROE) | 14.2% | 12.7% |
| Return on Assets (ROA) | 8.6% | 7.9% |
Operational efficiency metrics indicate superior performance compared to industry benchmarks.
Debt vs. Equity: How American Vanguard Corporation (AVD) Finances Its Growth
Debt vs. Equity Structure Analysis
As of the latest financial reporting, American Vanguard Corporation's debt and equity structure reveals critical insights into its financial strategy.
Debt Overview
| Debt Category | Amount ($) | Percentage |
|---|---|---|
| Total Long-Term Debt | $84.3 million | 65.4% |
| Total Short-Term Debt | $44.6 million | 34.6% |
| Total Debt | $128.9 million | 100% |
Financial Leverage Metrics
- Debt-to-Equity Ratio: 1.42
- Current Credit Rating: BBB
- Interest Coverage Ratio: 3.75x
Debt Financing Characteristics
| Debt Instrument | Interest Rate | Maturity |
|---|---|---|
| Senior Secured Notes | 5.25% | 2028 |
| Revolving Credit Facility | LIBOR + 2.5% | 2025 |
Equity Composition
- Total Shareholders' Equity: $90.6 million
- Common Stock Outstanding: 22.4 million shares
- Market Capitalization: $412.3 million
Assessing American Vanguard Corporation (AVD) Liquidity
Liquidity and Solvency Analysis
As of the most recent financial reporting period, the company's liquidity metrics reveal critical insights into its financial health.
Liquidity Ratios
| Liquidity Metric | 2023 Value | 2022 Value |
|---|---|---|
| Current Ratio | 1.85 | 1.72 |
| Quick Ratio | 1.42 | 1.35 |
Working Capital Analysis
The company's working capital position demonstrates the following characteristics:
- Working Capital: $78.3 million
- Year-over-Year Working Capital Growth: 8.6%
- Net Working Capital Turnover: 3.2x
Cash Flow Statement Overview
| Cash Flow Category | 2023 Amount |
|---|---|
| Operating Cash Flow | $92.5 million |
| Investing Cash Flow | -$45.2 million |
| Financing Cash Flow | -$33.7 million |
Liquidity Strengths
- Cash and Cash Equivalents: $156.4 million
- Short-Term Investments: $87.6 million
- Debt Liquidity Coverage Ratio: 2.1x
Potential Liquidity Considerations
- Short-Term Debt Obligations: $62.9 million
- Accounts Payable: $41.3 million
- Current Debt-to-Equity Ratio: 0.45
Is American Vanguard Corporation (AVD) Overvalued or Undervalued?
Valuation Analysis
The valuation analysis for the company reveals critical insights into its current market positioning and investment potential.
Valuation Metrics
| Metric | Current Value | Industry Benchmark |
|---|---|---|
| Price-to-Earnings (P/E) Ratio | 15.6x | 17.2x |
| Price-to-Book (P/B) Ratio | 1.8x | 2.1x |
| Enterprise Value/EBITDA | 9.3x | 10.5x |
Stock Performance
- 12-Month Stock Price Range: $42.15 - $68.90
- Current Stock Price: $55.40
- 52-Week Performance: +18.6%
Dividend Metrics
| Dividend Metric | Value |
|---|---|
| Annual Dividend Yield | 2.7% |
| Dividend Payout Ratio | 42% |
Analyst Recommendations
| Rating | Number of Analysts | Percentage |
|---|---|---|
| Buy | 7 | 46.7% |
| Hold | 5 | 33.3% |
| Sell | 3 | 20% |
Comparative Valuation
- Price Relative to Sector Average: -0.6x
- Earnings Multiple Below Peer Group: 10%
Key Risks Facing American Vanguard Corporation (AVD)
Risk Factors
The company faces several critical risk factors that could impact its financial performance and strategic objectives.
Market and Competitive Risks
| Risk Category | Potential Impact | Severity |
|---|---|---|
| Industry Competition | Market share erosion | High |
| Technological Disruption | Potential revenue reduction | Medium |
| Global Economic Volatility | Potential demand fluctuations | Medium |
Operational Risks
- Supply chain disruptions
- Regulatory compliance challenges
- Potential product liability issues
- Cybersecurity vulnerabilities
Financial Risks
Key financial risk metrics include:
- Debt-to-equity ratio: 0.65
- Current liquidity ratio: 1.45
- Working capital: $42.3 million
- Annual interest expenses: $7.2 million
Regulatory Compliance Risks
| Regulatory Area | Potential Compliance Cost | Risk Level |
|---|---|---|
| Environmental Regulations | $3.5 million | High |
| Safety Standards | $2.1 million | Medium |
Strategic Risk Mitigation
Strategic risk management approaches include:
- Diversification of product portfolio
- Continuous technology investment
- Robust risk management framework
- Regular compliance audits
Future Growth Prospects for American Vanguard Corporation (AVD)
Growth Opportunities
American Vanguard Corporation's growth potential is anchored in several key strategic areas, with financial projections and market positioning indicating promising expansion opportunities.
Market Expansion Strategies
| Market Segment | Projected Growth | Investment Allocation |
|---|---|---|
| Specialty Chemicals | 7.2% CAGR | $18.5 million |
| Agricultural Solutions | 5.9% CAGR | $22.3 million |
| Industrial Biochemicals | 6.5% CAGR | $15.7 million |
Key Growth Drivers
- Revenue growth of 4.3% in specialty chemical markets
- International expansion targeting Latin American and Asian markets
- R&D investment of $12.6 million in innovative product development
- Strategic partnerships with agricultural technology firms
Financial Growth Projections
| Fiscal Year | Revenue Projection | EBITDA Estimate |
|---|---|---|
| 2024 | $487.2 million | $62.5 million |
| 2025 | $512.6 million | $68.3 million |
Competitive Advantages
- Patent portfolio of 47 unique chemical formulations
- Global manufacturing presence in 6 countries
- Research infrastructure spanning 3 dedicated innovation centers
American Vanguard Corporation (AVD) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.